These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22935634)

  • 1. Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; Nambi V; Pankow JS; Tang W; Farbakhsh K; Yamagishi K; Boerwinkle E
    Atherosclerosis; 2012 Oct; 224(2):435-9. PubMed ID: 22935634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.
    Lusk CM; Dyson G; Clark AG; Ballantyne CM; Frikke-Schmidt R; Tybjærg-Hansen A; Boerwinkle E; Sing CF
    Hum Genet; 2014 Sep; 133(9):1105-16. PubMed ID: 24889828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.
    Gioli-Pereira L; Santos PC; Ferreira NE; Hueb WA; Krieger JE; Pereira AC
    BMC Cardiovasc Disord; 2012 Aug; 12():61. PubMed ID: 22856518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Marian AJ
    BMC Cardiovasc Disord; 2009 Jan; 9():3. PubMed ID: 19173706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.
    Brautbar A; Ballantyne CM; Lawson K; Nambi V; Chambless L; Folsom AR; Willerson JT; Boerwinkle E
    Circ Cardiovasc Genet; 2009 Jun; 2(3):279-85. PubMed ID: 20031596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of chromosome 9p21.3 region associated with coronary artery disease and premature coronary artery disease in an Asian Indian population.
    Kalpana B; Murthy DK; Balakrishna N; Aiyengar MT
    Indian Heart J; 2019; 71(3):263-271. PubMed ID: 31543200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic Status Interacts with the Genetic Effect of a Chromosome 9p21.3 Common Variant to Influence Coronary Artery Calcification and Incident Coronary Events in the Heinz Nixdorf Recall Study (Risk Factors, Evaluation of Coronary Calcium, and Lifestyle).
    Schmidt B; Frölich S; Dragano N; Frank M; Eisele L; Pechlivanis S; Forstner AJ; Nöthen MM; Mahabadi AA; Erbel R; Moebus S; Jöckel KH
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28411192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease.
    Virani SS; Brautbar A; Lee VV; MacArthur E; Morrison AC; Grove ML; Nambi V; Frazier L; Wilson JM; Willerson JT; Boerwinkle E; Ballantyne CM
    Circ J; 2012; 76(4):950-6. PubMed ID: 22322877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study.
    Yamagishi K; Folsom AR; Rosamond WD; Boerwinkle E;
    Eur Heart J; 2009 May; 30(10):1222-8. PubMed ID: 19329499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease.
    Horne BD; Carlquist JF; Muhlestein JB; Bair TL; Anderson JL
    Circ Cardiovasc Genet; 2008 Dec; 1(2):85-92. PubMed ID: 19956784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of type 2 diabetes mellitus with chromosome 9p21 rs10757274 polymorphism on the risk of myocardial infarction: a case-control study in Chinese population.
    Zhang LW; Li JP; Duan FF; Liu ZK; Zhan SY; Hu YH; Jiang J; Zhang Y; Huo Y; Chen DF
    BMC Cardiovasc Disord; 2014 Nov; 14():170. PubMed ID: 25430018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated polymorphisms in 9p21 are not associated with extreme longevity.
    Congrains A; Kamide K; Hirose N; Arai Y; Oguro R; Nakama C; Imaizumi Y; Kawai T; Kusunoki H; Yamamoto H; Onishi-Takeya M; Takeya Y; Yamamoto K; Sugimoto K; Akasaka H; Saitoh S; Miura T; Awata N; Kato N; Katsuya T; Ikebe K; Gondo Y; Rakugi H
    Geriatr Gerontol Int; 2015 Jun; 15(6):797-803. PubMed ID: 25257646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
    Gong Y; Beitelshees AL; Cooper-DeHoff RM; Lobmeyer MT; Langaee TY; Wu J; Cresci S; Province MA; Spertus JA; Pepine CJ; Johnson JA
    Circ Cardiovasc Genet; 2011 Apr; 4(2):169-78. PubMed ID: 21372283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease.
    Dandona S; Stewart AF; Chen L; Williams K; So D; O'Brien E; Glover C; Lemay M; Assogba O; Vo L; Wang YQ; Labinaz M; Wells GA; McPherson R; Roberts R
    J Am Coll Cardiol; 2010 Aug; 56(6):479-86. PubMed ID: 20670758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population.
    Akan G; Kisenge P; Sanga TS; Mbugi E; Adolf I; Turkcan MK; Janabi M; Atalar F
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):33-43. PubMed ID: 31472045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between diastolic blood pressure and coronary artery calcification is dependent on single nucleotide polymorphisms on chromosome 9p21.3.
    Kim DS; Smith JA; Bielak LF; Wu CY; Sun YV; Sheedy PF; Turner ST; Peyser PA; Kardia SL
    BMC Med Genet; 2014 Sep; 15():89. PubMed ID: 25185447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in loci 1p13 and 9p21 and fatal coronary heart disease in a Norwegian case-cohort study.
    Jansen MD; Knudsen GP; Myhre R; Høiseth G; Mørland J; Næss Ø; Tambs K; Magnus P
    Mol Biol Rep; 2014 May; 41(5):2733-43. PubMed ID: 24728607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.
    Dadu RT; Dodge R; Nambi V; Virani SS; Hoogeveen RC; Smith NL; Chen F; Pankow JS; Guild C; Tang WH; Boerwinkle E; Hazen SL; Ballantyne CM
    Circ Heart Fail; 2013 Sep; 6(5):936-43. PubMed ID: 23861484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SNP rs7865618 of 9p21.3 locus emerges as the most promising marker of coronary artery disease in the southern Indian population.
    Manjula G; Pranavchand R; Kumuda I; Reddy BS; Reddy BM
    Sci Rep; 2020 Dec; 10(1):21511. PubMed ID: 33298998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15).
    Landman GW; van Vliet-Ostaptchouk JV; Kleefstra N; van Hateren KJ; Drion I; Groenier KH; Gans RO; Snieder H; Hofker MH; Bilo HJ
    Cardiovasc Diabetol; 2012 Nov; 11():138. PubMed ID: 23134948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.